Navigating midlife and menopause often involves considering various supplements alongside prescribed medications. Evening primrose oil (EPO) is a popular choice for some women, but understanding its potential interactions with other medications, particularly anticoagulants, is important.
This article provides an evidence-based overview of what is currently understood regarding evening primrose oil and its possible effects on bleeding risk when used concurrently with anticoagulant medications. Our aim is to offer clear, non-hyped information to help you make informed personal health choices.
What are Anticoagulant Medications?
Anticoagulant medications, often referred to as ‘blood thinners,’ are prescribed to help reduce the risk of blood clots. They work by interfering with the blood clotting process in various ways. Common examples include warfarin, dabigatran, rivaroxaban, and apixaban. These medications are vital for individuals with certain health conditions, such as those with a history of stroke, heart conditions, or deep vein thrombosis.
Evening Primrose Oil: An Overview
Evening primrose oil is derived from the seeds of the evening primrose plant (Oenothera biennis). It is a source of gamma-linolenic acid (GLA), an omega-6 fatty acid. EPO is often used by women in midlife and menopause for various reasons, though the scientific evidence supporting many of its uses is limited [1].
While often considered a natural supplement, it’s important to remember that ‘natural’ does not always mean ‘without effect’ or ‘without potential interactions’ with other substances in the body.
The Potential Evening Primrose Oil Anticoagulant Interaction: What the Evidence Suggests
The primary concern regarding evening primrose oil and anticoagulant medications revolves around the potential for an increased risk of bleeding. It is worth being precise about where that concern comes from, because the reference work most often cited on drug-herb interactions does not actually name EPO on this point: its list of herbs that may alter bleeding time and should not be taken with warfarin is feverfew, garlic, Ginkgo, ginger and ginseng, and it mentions evening primrose oil only in connection with anticonvulsants and seizure threshold [2].
The effect of evening primrose oil on platelets, however, is not theoretical. In a randomized trial funded by the National Institutes of Health, postmenopausal women who supplemented with evening primrose oil showed reduced platelet aggregation in response to thrombin receptor stimulation, reduced dense granule secretion and lower baseline platelet integrin activation, with some of those changes still measurable after a washout period[4]. In rabbits given EPO for 30 and 60 days, every coagulation assay tested except fibrinogen time lengthened significantly, alongside a significantly reduced platelet count[5]. There is a defined route for it, too: the gamma-linolenic acid in EPO is converted to dihomo-gamma-linolenic acid, which the enzyme 12-lipoxygenase oxidises into a compound that inhibits platelet activation and thrombus formation[6]. A systematic review of concurrent prescription and herbal product use in older adults notes that anticoagulants and evening primrose oil are each among the most commonly used members of their categories in this age group, but reports no interaction outcome for the combination [3].
Two findings cut the other way, and they matter as much as the ones above. In the animal work, that same 12-lipoxygenase compound inhibited thrombus formation without prolonging bleeding: tail bleeding and arteriole rupture, the two hemostatic models tested, were both unchanged[6]. And in the one randomized trial that added evening primrose oil to an existing supplement regimen and measured platelet aggregation in people, the group taking concentrated fish oil together with EPO showed no statistically significant change in platelet function, while fish oil on its own did[7]. Reduced platelet reactivity in a laboratory assay is not the same thing as bleeding more, and the human evidence does not currently show that evening primrose oil makes people bleed.
What is genuinely missing is narrower than it first appears, and it is worth naming exactly. No published trial has given evening primrose oil to people who are taking warfarin, apixaban, rivaroxaban or dabigatran and then measured bleeding events, INR or any other clotting outcome. A PubMed search pairing evening primrose with anticoagulants returns only a handful of records, and none of them is that study. The platelet effect is measured and the drug combination is untested, and those are two different statements. There is also a published case of severe thrombocytopenia in a woman who had taken evening primrose oil and black seed oil daily for about a month before surgery, where the reporting clinicians named EPO’s recognised antiplatelet properties as a contributing factor alongside a consumptive coagulopathy[8]. A single case cannot establish cause, but it is the sort of signal that makes this a conversation to have with a prescriber rather than a question to settle alone.
Why the Concern Exists
The concern stems from the general understanding that certain fatty acids can influence prostaglandin pathways, which are involved in inflammation and blood clotting. If EPO were to significantly alter these pathways in a way that further reduced blood clotting, it could theoretically enhance the effects of anticoagulant medications, leading to a higher risk of bruising or bleeding.
The first half of that question has an answer. GLA does exert a measurable effect on platelet function at ordinary supplement intakes, and it has been measured in exactly the group this page is written for[4]. The second half does not. Whether that effect is large enough to compound the action of a prescription anticoagulant has never been tested, so its size in that specific situation is unquantified. Unquantified is not the same as absent, and it is not the same as proven either, which is why this belongs in a conversation with your prescriber rather than in a decision you make from a supplement label.
Current Recommendations and Safety
Given that the effect on platelets is real but its interaction with prescription anticoagulants is untested, the most prudent approach is caution. Healthcare providers generally advise individuals taking anticoagulant medications to be mindful of all supplements they consume, including evening primrose oil, due to the general potential for drug-herb interactions [2].
The lack of strong evidence does not equate to a lack of risk. Instead, it highlights the need for personalized medical advice. If you are taking an anticoagulant medication and are considering or currently using evening primrose oil, it is essential to discuss this with your prescribing doctor or pharmacist. They can assess your individual health profile, the specific anticoagulant you are taking, and help you understand any potential risks based on your unique circumstances.
Monitoring for Potential Signs of Interaction
If you are using both evening primrose oil and an anticoagulant, it is important to be aware of and monitor for any signs of increased bleeding. These might include easier bruising, nosebleeds, bleeding gums, prolonged bleeding from minor cuts, or dark or tarry stools. Any new or worsening bleeding symptoms should prompt immediate discussion with your healthcare provider.
Your doctor may recommend specific monitoring, such as blood tests, to ensure that your anticoagulant medication is working within the desired therapeutic range, especially if you introduce a new supplement like evening primrose oil.
References
- Oral evening primrose oil and borage oil for eczema. The Cochrane database of systematic reviews, 2013
- Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Archives of internal medicine, 1998
- Concurrent Use of Prescription Drugs and Herbal Medicinal Products in Older Adults: A Systematic Review. Drugs & aging, 2017
- Supplementation with omega-3 or omega-6 fatty acids attenuates platelet reactivity in postmenopausal women. Clinical and translational science, 2022
- Assessment of anticoagulant effect of evening primrose oil. Pakistan journal of pharmaceutical sciences, 2009
- 12(S)-HETrE, a 12-Lipoxygenase Oxylipin of Dihomo-γ-Linolenic Acid, Inhibits Thrombosis via Gαs Signaling in Platelets. Arteriosclerosis, thrombosis, and vascular biology, 2016
- Influence of different supplementation on platelet aggregation in patients with rheumatoid arthritis. Clinical rheumatology, 2019
- Severe Thrombocytopenia Associated With Black Seed Oil and Evening Primrose Oil. Cureus, 2020
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
